Namyang Dairy (003920)
Korea Stock Exchange · Korea · prices in KRW · close of 19 Oct 2026
Key indicators
| Last close | KRW 40,400.00 |
|---|---|
| 52-week range | 39,400.00 – 57,700.00 |
| Return, 1 month / 3 months | −6.4% / −4.9% |
| Return, 1 year / 3 years | −24.0% / −11.6% |
| Trend | Below its 200-day average |
| RSI (14) | 28 |
| Volatility (1 year) | 30.2% |
| Worst drawdown (1 year) | -28.3% |
| Average daily value traded | 153.81M KRW |
| Dividend yield | 3.5% |
Market X-Ray price-based
Five-year price chart navy: price · brown: 200-day average
About the company
Namyang Dairy Products is a South Korean dairy company that makes and sells milk, yogurt, cheese, butter and infant formula. It supplies households through retail shops and also sells dairy ingredients and food products to business customers. The company is based in South Korea and sells under its own brands, including infant nutrition lines, with a product range that covers everyday dairy foods and specialty milk products for families and children.
On this site Namyang Dairy appears as a stock on the Korea Stock Exchange (Korea), code 003920, with prices in South Korean won (KRW). Our dividend records, which start in 2019, show payments in 7 different calendar years. The Market X-Ray on this page is price-based and compares it with other stocks on the same exchange; it does not measure how healthy the business is.
Summary
Namyang Dairy (003920) trades on the Korea Stock Exchange in Korea. It last closed at KRW 40,400.00 on 19 October 2026.
Its price-based Market X-Ray is 51 out of 100 (a fair price profile), ranking 465 of 934 stocks on this exchange. The score describes how the stock has traded: trend, momentum, risk, liquidity and dividends, each ranked against the other stocks on its own exchange. It does not measure how healthy or cheap the business is.
Over the last year the price fell 24.0% and over the last three months it fell 4.9%. Returns are price returns, dividends not included.
Fundamental measures (valuation, growth, financial health) are not shown: we do not yet hold financial statements for this market.
The five lenses in numbers each metric is ranked against the other stocks on Korea Stock Exchange
| Lens and metric | Value | Score | Reading |
|---|---|---|---|
| Trend | 50 · Fair | Mixed trend against its averages. | |
| Above 200-day average | -13.9% | ||
| From 52-week high | -28.1% | ||
| Momentum | 32 · Weak | Lagging most stocks on this exchange. | |
| 3-month return | -4.9% | ||
| 6-month return | -22.6% | ||
| 12-month return, skipping the last month | -18.8% | ||
| Risk (lower is better) | 84 · Strong | Calmer than most: low volatility and shallow drawdowns. | |
| Volatility (1 year) | 30.2% | ||
| Worst drawdown (1 year) | -28.3% | ||
| Liquidity | 27 · Weak | Thinly traded: prices can jump and exits can be hard. | |
| Average daily value traded | 153.81M KRW | ||
| Zero-volume days | 0.0% | ||
| Income | 54 · Fair | Dividend is typical for this exchange. | |
| Dividend yield | 3.5% | ||
| Years with dividends | 5 |
Strengths
- Risk (lower is better): Calmer than most: low volatility and shallow drawdowns.
Weak spots
- Momentum: Lagging most stocks on this exchange.
- Liquidity: Thinly traded: prices can jump and exits can be hard.
Returns
| 1 week | −2.2% |
|---|---|
| 1 month | −6.4% |
| 3 months | −4.9% |
| 6 months | −22.6% |
| 1 year | −24.0% |
| 3 years | −11.6% |
| 5 years | – |
Signals
| 50-day / 200-day average | 42,865.00 / 46,922.13 |
|---|---|
| Golden / death cross (60 days) | None |
| New 52-week high | No |
| Bullish RSI divergence | No |
| Average daily range (ATR) | 1,140.41 |
Technical summary
Recent dividends
| Ex-dividend date | Amount per share |
|---|---|
| 29 Dec 2025 | KRW 1,428.0000 |
| 27 Dec 2024 | KRW 100.0000 |
| 27 Dec 2023 | KRW 1,000.0000 |
| 28 Dec 2022 | KRW 1,000.0000 |
| 29 Dec 2021 | KRW 1,000.0000 |
| 29 Dec 2020 | KRW 1,000.0000 |
How to read this report
Every number comes from end-of-day prices and dividends. The Market X-Ray describes how the stock has traded, ranked against the other stocks on Korea Stock Exchange; it does not measure how healthy or cheap the business is. The fundamental X-Ray (financial health, valuation, growth) needs financial statements, which we hold today for US stocks. See the methodology page. Educational only, not financial advice.